Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression

American Heart Journal

Volumn 153, Issue 4, 2007, Pages 587-593

  Biondi Zoccai, Giuseppe G L ^a   Lotrionte, Marzia ^b   Agostoni, Pierfrancesco ^c   Valgimigli, Marco ^d   Abbate, Antonio ^e   Sangiorgi, Giuseppe ^f   Moretti, Claudio ^a   Sheiban, Imad ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c MIDDELHEIM HOSPITAL   (Belgium)

^d UNIVERSITY OF FERRARA   (Italy)

^e VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE;

ADD ON THERAPY; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CORONARY STENT; DRUG EFFICACY; FOLLOW UP; HEART INFARCTION; HUMAN; INFORMATION RETRIEVAL; LOADING DRUG DOSE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZATION; REGRESSION ANALYSIS; RISK ASSESSMENT; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION;

COMBINED MODALITY THERAPY; CORONARY ARTERIOSCLEROSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; STENTS; TICLOPIDINE;

EID: 33947393182     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.01.007     Document Type: Article

References (50)

1. Colombo A., Hall P., Nakamura S., et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 91 (1995) 1676-1688
2. Leon M.B., Baim D.S., Popma J.J., et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 339 (1998) 1665-1671
3. Quinn M.J., and Fitzgerald D.J. Ticlopidine and clopidogrel. Circulation 100 (1999) 1667-1672
4. Bhatt D.L., Bertrand M.E., Berger P.B., et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 39 (2002) 9-14
5. Casella G., Ottani F., Pavesi P.C., et al. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis. Ital Heart J 4 (2003) 677-684
6. Biondi-Zoccai G.G., Agostoni P., Testa L., et al. Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis. Minerva Cardioangiol 52 (2004) 195-208
7. Schleinitz M.D., Olkin I., and Heidenreich P.A. Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials. Am Heart J 148 (2004) 990-997
8. Mueller C., Roskamm H., Neumann F.J., et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 41 (2003) 969-973
9. Biondi-Zoccai G.G., Sangiorgi G.M., Chieffo A., et al. Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era. Am J Cardiol 95 (2005) 1466-1468
10. Biondi-Zoccai G.G.L., Lotrionte M., Agostoni P., et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
11. Biondi-Zoccai G.G., Agostoni P., and Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 4 (2003) 819-820
12. Thompson S.G., and Higgins J.P. How should meta-regression analyses be undertaken and interpreted?. Stat Med 21 (2002) 1559-1573
13. Biondi-Zoccai G.G., Abbate A., Agostoni P., et al. Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression. Am Heart J 149 (2005) 504-511
14. Biondi-Zoccai G.G., Testa L., and Agostoni P. A practical algorithm for systematic reviews in cardiovascular medicine. Ital Heart J 5 (2004) 486-487
15. Biondi-Zoccai G.G., Agostoni P., Abbate A., et al. A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 34 (2005) 224-225
16. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
17. Peters J.L., Sutton A.J., Jones D.R., et al. Comparison of two methods to detect publication bias in meta-analysis. JAMA 295 (2006) 676-680
18. Gawaz M., Seyfarth M., Muller I., et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol 87 (2001) 332-336
19. Seyfarth H.J., Koksch M., Roethig G., et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J 143 (2002) 118-123
20. Wolak A., Amit G., Cafri C., et al. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation. Int J Cardiol 103 (2005) 293-297
21. De Luca G., Suryapranata H., van't Hof A.W., et al. Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stenting. Thromb Haemost 91 (2004) 1084-1089
22. L'Allier P.L., Aronow H.D., Cura F.A., et al. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting. Can J Cardiol 19 (2003) 1041-1046
23. Kastrati A., Mehilli J., Schuhlen H., et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med 350 (2004) 232-238
24. Bertrand M.E., Rupprecht H.J., Urban P., et al., for the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 102 (2000) 624-629
25. Taniuchi M., Kurz H.I., and Lasala J.M. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 104 (2001) 539-543
26. Piamsomboon C., Laothavorn P., Chatlaong B., et al. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up. J Med Assoc Thai 84 (2001) 1701-1707
27. Atmaca Y., Dandachi R., Gulec S., et al. Comparison of clopidogrel versus ticlopidine for prevention of minor myocardial injury after elective coronary stenting. Int J Cardiol 87 (2003) 143-149
28. Parodi G., Sciagra R., Migliorini A., et al. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy. Am Heart J 150 (2005) 220
29. Juergens C.P., Wong A.M., Leung D.Y., et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation. Am Heart J 147 (2004) E15
30. Steinhubl S.R., Berger P.B., Mann III J.T., et al., for the CREDO Investigators (Clopidogrel for the Reduction of Events During Observation). Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
31. Yusuf S., Zhao F., Mehta S.R., et al., for the Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345 (2001) 494-502
32. Dangas G., Mehran R., Abizaid A.S., et al. Combination therapy with aspirin plus clopidogrel versus aspirin plus ticlopidine for prevention of subacute thrombosis after successful native coronary stenting. Am J Cardiol 87 (2001) 470-472
33. Steinhubl S.R., Lauer M.S., Mukherjee D.P., et al. The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. J Am Coll Cardiol 32 (1998) 1366-1370
34. Gurbel P.A., Cummings C.C., Bell C.R., et al. Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. Am Heart J 145 (2003) 239-247
35. Blanchard D., Demicheli T., and Danchin N. Premedication by thienopyridine before percutaneous coronary interventions in unstable angina. Ann Cardiol Angeiol (Paris) 52 (2003) 169-172
36. Patti G., Colonna G., Pasceri V., et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 111 (2005) 2099-2106
37. Biondi-Zoccai G.G., Agostoni P., Abbate A., et al. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. Int J Cardiol 100 (2005) 119-123
38. Biondi-Zoccai G.G., Agostoni P., Sangiorgi G.M., et al. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxus in Real-life Usage Evaluation) Study. Int J Cardiol 108 (2006) 406-407
39. von Beckerath N., Taubert D., Pogatsa-Murray G., et al. Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 112 (2005) 2946-2950
40. Montalescot G., Sideris G., Meuleman C., et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. J Am Coll Cardiol 48 (2006) 931-938
41. Kastrati A., Mehilli J., Neumann F.J., et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. JAMA 295 (2006) 1531-1538
42. Steinhubl S.R., Tan W.A., Foody J.M., et al. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 281 (1999) 806-810
43. Symeonidis A., Kouraklis-Symeonidis A., Seimeni U., et al. Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases. Am J Hematol 71 (2002) 24-32
44. Kereiakes D.J., and Willerson J.T. Therapeutic substitution: guilty until proven innocent. Circulation 108 (2003) 2611-2612
45. Valgimigli M., Percoco G., Barbieri D., et al. The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. J Am Coll Cardiol 44 (2004) 14-19
46. Lee S.W., Park S.W., Hong M.K., et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 46 (2005) 1833-1837
47. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., et al. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J 25 (2004) 1903-1910
48. Geisler T., Langer H., Wydymus M., et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27 (2006) 2420-2425
49. Hankey G.J., and Eikelboom J.W. Aspirin resistance. Lancet 367 (2006) 606-617
50. Fuchigami S., Oshima S., Hokimoto S., et al. Subacute thrombosis after coronary stenting occurring with resistance to ticlopidine. Intern Med 45 (2006) 675-678